Dillon & Associates Inc Johnson & Johnson Transaction History

Dillon & Associates Inc

  • $711 Million
  • Q3 2024

A detailed history of Dillon & Associates Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Dillon & Associates Inc holds 24,547 shares of JNJ stock, worth $3.56 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
24,547
Previous 24,760 0.86%
Holding current value
$3.56 Million
Previous $3.62 Million 10.01%
% of portfolio
0.56%
Previous 0.53%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
SELL
$145.48 - $167.38 $30,987 - $35,651
-213 Reduced 0.86%
24,547 $3.98 Million
Q2 2024

Aug 06, 2024
SELL
$144.38 - $157.78 $40,137 - $43,862
-278 Reduced 1.11%
24,760 $3.62 Million
Q1 2024

Apr 30, 2024
SELL
$155.22 - $162.74 $108,809 - $114,080
-701 Reduced 2.72%
25,038 $3.96 Million
Q4 2023

Feb 08, 2024
SELL
$145.6 - $158.88 $271,398 - $296,152
-1,864 Reduced 6.75%
25,739 $4.04 Million
Q3 2023

Nov 13, 2023
SELL
$155.75 - $174.48 $54,512 - $61,068
-350 Reduced 1.25%
27,603 $4.31 Million
Q2 2023

Aug 08, 2023
SELL
$154.35 - $166.11 $130,425 - $140,362
-845 Reduced 2.93%
27,953 $4.64 Million
Q1 2023

May 02, 2023
SELL
$151.05 - $180.26 $553,598 - $660,652
-3,665 Reduced 11.29%
28,798 $4.46 Million
Q1 2023

May 01, 2023
BUY
$151.05 - $180.26 $265,696 - $317,077
1,759 Added 5.73%
32,463 $5.03 Million
Q4 2022

Feb 06, 2023
SELL
$160.2 - $179.79 $134,087 - $150,484
-837 Reduced 2.65%
30,704 $5.44 Million
Q3 2022

Nov 08, 2022
BUY
$161.33 - $179.52 $16,133 - $17,952
100 Added 0.32%
31,541 $5.14 Million
Q2 2022

Jul 26, 2022
SELL
$168.19 - $186.01 $84,095 - $93,005
-500 Reduced 1.57%
31,441 $5.6 Million
Q1 2022

May 06, 2022
SELL
$158.14 - $179.59 $82,549 - $93,745
-522 Reduced 1.61%
31,941 $5.65 Million
Q4 2021

Feb 14, 2022
BUY
$155.93 - $173.01 $13,098 - $14,532
84 Added 0.26%
32,463 $5.55 Million
Q3 2021

Oct 28, 2021
SELL
$161.5 - $179.47 $89,632 - $99,605
-555 Reduced 1.69%
32,379 $5.25 Million
Q2 2021

Aug 02, 2021
SELL
$159.48 - $171.07 $215,298 - $230,944
-1,350 Reduced 3.94%
32,934 $5.43 Million
Q1 2021

May 10, 2021
SELL
$153.07 - $170.48 $264,811 - $294,930
-1,730 Reduced 4.8%
34,284 $5.62 Million
Q4 2020

Feb 12, 2021
SELL
$137.11 - $157.38 $63,070 - $72,394
-460 Reduced 1.26%
36,014 $5.65 Million
Q3 2020

Nov 06, 2020
SELL
$140.38 - $153.83 $64,434 - $70,607
-459 Reduced 1.24%
36,474 $5.44 Million
Q2 2020

Jul 28, 2020
SELL
$128.81 - $155.51 $10,948 - $13,218
-85 Reduced 0.23%
36,933 $5.21 Million
Q1 2020

May 07, 2020
SELL
$111.14 - $153.99 $933,576 - $1.29 Million
-8,400 Reduced 18.49%
37,018 $4.85 Million
Q4 2019

Feb 03, 2020
SELL
$127.5 - $146.44 $925,012 - $1.06 Million
-7,255 Reduced 13.77%
45,418 $6.63 Million
Q3 2019

Oct 25, 2019
SELL
$126.95 - $142.14 $376,914 - $422,013
-2,969 Reduced 5.34%
52,673 $6.8 Million
Q2 2019

Jul 22, 2019
SELL
$131.15 - $144.24 $32,787 - $36,060
-250 Reduced 0.45%
55,642 $7.73 Million
Q1 2019

May 07, 2019
SELL
$125.72 - $139.79 $49,659 - $55,217
-395 Reduced 0.7%
55,892 $7.83 Million
Q4 2018

Feb 14, 2019
SELL
$122.84 - $147.84 $193,227 - $232,552
-1,573 Reduced 2.72%
56,287 $7.26 Million
Q3 2018

Nov 14, 2018
SELL
$121.58 - $142.88 $88,631 - $104,159
-729 Reduced 1.24%
57,860 $7.99 Million
Q2 2018

Aug 08, 2018
SELL
$119.4 - $131.76 $87,162 - $96,184
-730 Reduced 1.23%
58,589 $7.09 Million
Q1 2018

May 08, 2018
SELL
$125.1 - $148.14 $93,699 - $110,956
-749 Reduced 1.25%
59,319 $7.59 Million
Q4 2017

Feb 08, 2018
SELL
$131.22 - $143.62 $179,771 - $196,759
-1,370 Reduced 2.23%
60,068 $8.41 Million
Q3 2017

Nov 13, 2017
SELL
$129.47 - $135.38 $67,971 - $71,074
-525 Reduced 0.85%
61,438 $7.99 Million
Q2 2017

Aug 09, 2017
BUY
N/A
61,963
61,963 $8.18 Million

Others Institutions Holding JNJ

# of Institutions
4,275
Shares Held
1.68B
Call Options Held
17.6M
Put Options Held
14.5M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $379B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Dillon & Associates Inc Portfolio

Follow Dillon & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dillon & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dillon & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email